OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
31
Results
Show all
Save search
Copy query
Show results for
Unknown
(31)
Release Date
2021
(9)
2023
(6)
2022
(5)
2025
(4)
2016
(2)
2024
(1)
2020
(1)
2013
(1)
2011
(1)
2010
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Researching COVID to enhance recovery (RECOVER) pregnancy study: Rationale, objectives and design.
Not available
S-EPMC10168506
|
biostudies-literature
Cite
Researching COVID to enhance recovery (RECOVER) pregnancy study: Rationale, objectives and design.
Not available
S-EPMC10734909
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design.
Not available
S-EPMC10289397
|
biostudies-literature
Cite
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height.
Not available
S-EPMC3014369
|
biostudies-literature
Cite
Hundreds of variants clustered in genomic loci and biological pathways affect human height.
Not available
S-EPMC2955183
|
biostudies-literature
Cite
Study of the doubly charmed tetraquark [Formula: see text].
Not available
S-EPMC9203551
|
biostudies-literature
Cite
Mining the human phenome using allelic scores that index biological intermediates.
Not available
S-EPMC3814299
|
biostudies-literature
Cite
Delaying surgery for patients with a previous SARS-CoV-2 infection.
Not available
S-EPMC7537063
|
biostudies-literature
Cite
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets